Plasma parathyroid hormone, phosphatemia and vitamin D receptor genotype: Are they interrelated?

Journal of Nephrology

Volumn 13, Issue 1, 2000, Pages 54-58

  Chudek, Jerzy ^a   Karkoszka, Henryk ^a   Schmidt Gayk, Heinrich ^b   Ritz, Eberhard ^b   Kokot, Franciszek ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Hemodialysis; Phosphates; Polymorphism; PTH; Secondary hyperparathyroidism; Vitamin D receptor

Indexed keywords

ALUMINUM HYDROXIDE; ALUSAL; CALCIUM CARBONATE; PARATHYROID HORMONE; PHOSPHATE; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ADULT; ARTICLE; CHRONIC GLOMERULONEPHRITIS; CHRONIC PYELONEPHRITIS; DIABETIC NEPHROPATHY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; NEPHROSCLEROSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; SECONDARY HYPERPARATHYROIDISM;

AGED; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; RECEPTORS, CALCITRIOL; RENAL DIALYSIS;

EID: 0034017536     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Slatopolsky E. The role of calcium, phosphorus and vitamin D metabolism in the development of secondary hyperparathyroidism. Nephrol Dial Transplant 1998; 13 (suppl 3): S3-8.
2. Kilav R, Silver J, Naveh-Many T. Parathyroid hormone gene expression in hypophosphatemic rats. J Clin Invest 1995; 96: 327-33.
3. Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, MacDonald PN, Brown AJ. Phosphorus restriction prevents parathyroid gland growth: High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 1996; 97: 2534-40.
4. Kates DM, Sherrard DJ, Andress DL. Evidence that plasma phosphate is independently associated with plasma PTH in patients with chronic renal failure. Am J Kidney Dis 1997; 25: 879-86.
5. Canalejo A, Hernandez A, Almaden J, Concepcion MT, Felsenfeld A, Torres A, Rodriquez M. The effect of a high phosphorus diet on the parathyroid cell cycle. Nephrol Dial Transplant 1998; 13: 19-22.
6. Miyamoto K, Tatsumi S, Morita K, Takeda E. Does the parathyroid "see" phosphate? Nephrol Dial Transplant 1998; 13: 2727-9.
7. Karkoszka H, Chudek J, Strzelczyk P, Wiecek A, Schmidt-Gayk H, Ritz E, Kokot F. Does the vitamin D receptor genotype prediet bone mineral loss in haemodialysed patients? Nephrol Dial Transplant 1998; 13: 2077-80.
8. Schmidt S, Chudek J, Karkoszka H, Heemann U, Reichel H, Rambausek M, Kokot F, Ritz E. The Bsml vitamin D receptor polymorphism and secondary hyperparathyroidism. Nephrol Dial Transplant 1997; 12: 1771-2.
9. Torres A, Machado M, Concepcion MT, Martin N, Lorenzo V, Hernandez D, Rodriquez AP, De Bonis E, Gonzalez-Posada JM, Hernandez A, Salido E. Influence of vitamin D receptor genotype on bone mass changes after renal transplantation. Kidney Int 1996; 50: 1726-33.
10. Scharla S, Schmidt-Gayk H, Reichel H, Mayer E. A sensitive and simplified radioimmunoassay for 1,25 - dihydroxyvitamin D. Clin Chim Acta 1984; 142: 325-38.
11. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284-7.
12. Fernandez E, Fibla J, Betriu A, Piulats JM, Almirall J, Montoliu J. Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure. J Am Soc Nephrol 1997; 8: 1564-52.
13. Garnero P, Borel O, Sornay-Rendu E, Arlot ME, Delmas PD. Vitamin D receptor gene polymorphism is not related to bone turnover, rate of bone loss, and bone mass in post-menopausal women: The OFELY study. J Bone Miner Res 1996; 11: 827-34.
14. Cross HS, Debiec H, Peterlik M. Mechanism and regulation of intestinal phosphate absorption. Miner Electrolyte Metab 1990; 16: 115-24.
15. Murer H, Biber J. Molecular mechanism in renal phosphate reabsorption. Nephrol Dial Transplant 1995; 10: 1501-4.